SELLAS Life Sciences Group, Inc. has grown revenue −35% a year over three years and −44% a year over five. Revenue growth, 3-year annual rate: −35% (Biotechnology median +21%). Revenue growth, 5-year rate: −44%, growth has picked up over the last three years. Years of annual history on file: 16, FY2010 to FY2025, as filed.

SLSSELLAS Life Sciences Group, Inc.

HealthcareUSD

$13.73

$1.3952 weeks$15.47

Is it growing?

Is SLS growing?

SELLAS Life Sciences Group, Inc. has grown revenue −35% a year over three years and −44% a year over five.

−35%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: −44%
Revenue growth, 5-year rate · −35% over three · growth has picked up over the last three years
Years of annual history on file: 16
Years of annual history on file · FY2010 to FY2025, as filed

Details›